BioSpace News Archive

ROCKVILLE, Md. , Feb. 13, 2020 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the Canadian Patent Office has issued a new patent to the Henry Ford Health System (HFHS) for treating patients with peripheral neuro

NEW YORK , Feb. 13, 2020 /PRNewswire/ --The most comprehensive molecular study of endometrial cancer to date has further defined the contributions of key genes and proteins to the disease, say its authors. Published online February 13 in Cell , the study suggests new treatment approaches that could be tailored for each patient, as well as potential biological targets

Feb. 13, 2020 18:00 UTC LAUSANNE, Switzerland & BOSTON--( BUSINESS WIRE )-- SOPHiA GENETICS, leader in Data-Driven Medicine, announced today the appointment of Philippe Menu, MD-PhD, MBA, as Chief Medical Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200213005647/en/ Dr. Philippe Menu joins SOPHiA GENETICS (Photo: SOPHiA GENETICS) Dr. Philippe Menu brings a unique blend of medical expertise acr

XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) today announced the preliminary results of its “modified Dutch auction” tender offer, which expired at 5:00 p.m., New York City time, on February 12, 2020.

Every 40 seconds, one American has a heart attack – and nearly 1 in 4 people who have had a heart attack will have another one.

LifePod® Solutions, the first proactive-voice caregiving service, today announced Dr. John Loughnane’s appointment as Chief Medical Advisor.

Rosalind Franklin University of Medicine and Science announced a research collaboration with the Chicagoland biotech company Exicure Inc. to develop new therapeutics for genetic diseases.